iShares Neuroscience and Healthcare ETF (IBRN) Alternatives
iShares Neuroscience and Healthcare ETF (IBRN) belongs to the Health & Biotech Equities category. Below you'll find alternative ETFs from the same category, ranked by key criteria, plus funds that investors commonly compare with IBRN. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.
Cheapest Alternatives to IBRN
IBRN charges 0.47% annually. Among ETFs in the Health & Biotech Equities category, these options have the lowest expense ratios among IBRN alternatives.
| Symbol | Name | Expense Ratio | Inception | |
|---|---|---|---|---|
| Fidelity MSCI Health Care Index ETF | 0.08% | Oct 21, 2013 | IBRN vs FHLC | |
| State Street Health Care Select Sector SPDR ETF | 0.08% | Dec 16, 1998 | IBRN vs XLV | |
| Vanguard Health Care ETF | 0.10% | Jan 26, 2004 | IBRN vs VHT | |
| Invesco S&P SmallCap Health Care ETF | 0.29% | Apr 7, 2010 | IBRN vs PSCH | |
| SPDR S&P Pharmaceuticals ETF | 0.35% | Jun 19, 2006 | IBRN vs XPH |
Best Risk-Adjusted Alternatives to IBRN
Among ETFs in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.
| Symbol | Name | Risk / Return Rank | Inception | |
|---|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 97 | Dec 16, 2014 | IBRN vs BBC | |
| ALPS Medical Breakthroughs ETF | 95 | Dec 31, 2014 | IBRN vs SBIO | |
| SPDR S&P Biotech ETF | 92 | Feb 6, 2006 | IBRN vs XBI | |
| Tema Oncology ETF | 90 | Aug 14, 2023 | IBRN vs CANC | |
| F/m Emerald Life Sciences Innovation ETF | 86 | Oct 30, 2024 | IBRN vs LFSC |
Top Performing IBRN Alternatives (YTD)
IBRN alternatives from the Health & Biotech Equities category, sorted by year-to-date return.
| Symbol | Name | YTD Return | Inception | |
|---|---|---|---|---|
| iShares Genomics Immunology and Healthcare ETF Gen... | 10.92% | Jun 11, 2019 | IBRN vs IDNA | |
| Virtus LifeSci Biotech Clinical Trials ETF | 7.95% | Dec 16, 2014 | IBRN vs BBC | |
| Tema Oncology ETF | 5.69% | Aug 14, 2023 | IBRN vs CANC | |
| SPDR S&P Biotech ETF | 4.76% | Feb 6, 2006 | IBRN vs XBI | |
| First Trust Nasdaq Pharmaceuticals ETF | 4.48% | Sep 20, 2016 | IBRN vs FTXH |
Lowest Volatility Alternatives to IBRN
IBRN alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.
| Symbol | Name | Volatility 1Y | Inception | |
|---|---|---|---|---|
| Principal Healthcare Innovators Index ETF | 0.00% | Aug 19, 2016 | IBRN vs BTEC | |
| Loncar Cancer Immunotherapy ETF | 0.00% | Oct 13, 2015 | IBRN vs CNCR | |
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | IBRN vs GERM | |
| Horizon Kinetics SPAC Active ETF | 8.60% | Jun 29, 2007 | IBRN vs SPAQ | |
| Global X Aging Population ETF | 15.94% | May 9, 2016 | IBRN vs AGNG |
Lowest Drawdown Alternatives to IBRN
IBRN alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.
| Symbol | Name | Max Drawdown 1Y | Inception | |
|---|---|---|---|---|
| Amplify Treatments, Testing and Advancements ETF | 0.00% | Jun 17, 2020 | IBRN vs GERM | |
| Horizon Kinetics SPAC Active ETF | -5.30% | Jun 29, 2007 | IBRN vs SPAQ | |
| Jpmorgan Healthcare Leaders ETF | -9.68% | Nov 1, 2023 | IBRN vs JDOC | |
| VanEck Vectors Pharmaceutical ETF | -10.02% | Dec 20, 2011 | IBRN vs PPH | |
| Global X Aging Population ETF | -10.16% | May 9, 2016 | IBRN vs AGNG |
Other ETFs from iShares
Most popular iShares ETFs on PortfoliosLab, across asset classes.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | Inception | |
|---|---|---|---|---|---|---|
| iShares 0-3 Month Treasury Bond ETF | Ultrashort Bond | 100 | 0.86% | May 26, 2020 | IBRN vs SGOV | |
| iShares Bitcoin Trust ETF | Cryptocurrency | 6 | -22.62% | Jan 5, 2024 | IBRN vs IBIT | |
| iShares Core S&P 500 ETF | S&P 500 | 65 | -4.38% | May 15, 2000 | IBRN vs IVV | |
| iShares 20+ Year Treasury Bond ETF | Government Bonds, Long-Term Bond | 12 | 0.17% | Jul 22, 2002 | IBRN vs TLT | |
| iShares Core Dividend Growth ETF | Large Cap Growth Equities, Dividend | 69 | 1.57% | Jun 10, 2014 | IBRN vs DGRO | |
| iShares Silver Trust | Precious Metals | 89 | 5.77% | Apr 21, 2006 | IBRN vs SLV | |
| iShares Semiconductor ETF | Semiconductors, Technology Equities | 92 | 9.20% | Jul 10, 2001 | IBRN vs SOXX | |
| iShares Gold Trust | Gold, Precious Metals | 87 | 8.61% | Jan 21, 2005 | IBRN vs IAU | |
| iShares Russell 2000 ETF | Small Cap Blend Equities | 69 | 0.93% | May 22, 2000 | IBRN vs IWM | |
| iShares MSCI ACWI ETF | Large Cap Growth Equities | 75 | -2.21% | Mar 26, 2008 | IBRN vs ACWI |
Often Compared With IBRN
What investors most often compare with IBRN, based on PortfoliosLab usage data.
| Symbol | Name | Category | Risk / Return Rank | YTD Return | Inception | |
|---|---|---|---|---|---|---|
| Vanguard S&P 500 ETF | S&P 500 | 65 | -4.42% | Sep 7, 2010 | IBRN vs VOO | |
| Harbor Health Care ETF | Health & Biotech Equities | 36 | -6.79% | Nov 16, 2022 | IBRN vs MEDI | |
| State Street SPDR S&P 500 ETF | S&P 500 | 64 | -4.37% | Jan 22, 1993 | IBRN vs SPY | |
| iShares U.S. Medical Devices ETF | Health & Biotech Equities | 3 | -14.09% | May 5, 2006 | IBRN vs IHI | |
| Invesco Dynamic Pharmaceuticals ETF | Health & Biotech Equities | 62 | -0.44% | Jun 23, 2005 | IBRN vs PJP | |
| SPDR S&P Health Care Services ETF | Health & Biotech Equities | 16 | -6.26% | Sep 28, 2011 | IBRN vs XHS | |
| Invesco S&P 500 Equal Weight Health Care ETF | Health & Biotech Equities, S&P 500 | 16 | -5.02% | Nov 1, 2006 | IBRN vs RSPH | |
| WisdomTree BioRevolution Fund | Health & Biotech Equities | 78 | 2.99% | Jun 3, 2021 | IBRN vs WDNA | |
| iShares Global Healthcare ETF | Health & Biotech Equities | 20 | -3.96% | Nov 13, 2001 | IBRN vs IXJ |
Compare IBRN with Any Fund or Stock
Compare IBRN with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.